Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 6024 | 2020 |
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ... Clinical infectious diseases 63 (4), e1-e60, 2016 | 2843 | 2016 |
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1959 | 2020 |
Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1797 | 2021 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled … JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ... The Lancet 387 (10020), 760-769, 2016 | 886 | 2016 |
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ... The Lancet infectious diseases 16 (7), 828-837, 2016 | 674 | 2016 |
Coccidioidomycosis: epidemiology J Brown, K Benedict, BJ Park, GR Thompson III Clinical epidemiology, 185-197, 2013 | 310 | 2013 |
Oropharyngeal candidiasis in the era of antiretroviral therapy GR Thompson III, PK Patel, WR Kirkpatrick, SD Westbrook, D Berg, ... Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2010 | 245 | 2010 |
The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ... Drugs 81, 1703-1729, 2021 | 236 | 2021 |
Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation G Jiang, EA Mendes, P Kaiser, DP Wong, Y Tang, I Cai, A Fenton, ... PLoS pathogens 11 (7), e1005066, 2015 | 204 | 2015 |
Overview of antifungal agents GR Thompson, J Cadena, TF Patterson Clinics in chest medicine 30 (2), 203-215, 2009 | 197 | 2009 |
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ... Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008 | 195 | 2008 |
Isavuconazole treatment of cryptococcosis and dimorphic mycoses GR Thompson, A Rendon, R Ribeiro dos Santos, F Queiroz-Telles, ... Reviews of Infectious Diseases 63 (3), 356-362, 2016 | 187 | 2016 |
Valley Fever: Finding New Places for an Old Disease: Coccidioides immitis Found in Washington State Soil Associated With Recent Human Infection AP Litvintseva, N Marsden-Haug, S Hurst, H Hill, L Gade, EM Driebe, ... Clinical Infectious Diseases 60 (1), e1-e3, 2015 | 181 | 2015 |
Aspiring antifungals: review of current antifungal pipeline developments TJ Gintjee, MA Donnelley, GR Thompson III Journal of Fungi 6 (1), 28, 2020 | 175 | 2020 |
Coccidioidomycosis NW Stockamp, GR Thompson Infectious Disease Clinics 30 (1), 229-246, 2016 | 174 | 2016 |
Invasive aspergillosis: current strategies for diagnosis and management J Cadena, GR Thompson, TF Patterson Infectious Disease Clinics 30 (1), 125-142, 2016 | 168 | 2016 |
Fungal disease of the nose and paranasal sinuses GR Thompson III, TF Patterson Journal of allergy and clinical immunology 129 (2), 321-326, 2012 | 163 | 2012 |
Aspergillosis: epidemiology, diagnosis, and treatment J Cadena, GR Thompson, TF Patterson Infectious Disease Clinics 35 (2), 415-434, 2021 | 160 | 2021 |
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole GR Thompson, NP Wiederhold Mycopathologia 170, 291-313, 2010 | 158 | 2010 |